Get startedLog in
    Picture of ExpreS2ion Biotech Holding AB logo

    EXPRS2 — ExpreS2ion Biotech Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: ExpreS2ion To Support COVID-19 Diagnostic Antibody Development Project

    Picture of ExpreS2ion Biotech Holding AB logoExpreS2ion Biotech Holding AB
    04/05/2020 08:03
    May 4 (Reuters) - ExpreS2ion Biotech Holding AB  EXPRS2.ST :
    * EXPRES2ION ANNOUNCES SUPPORTING AN ADVANTAGEOUS COVID-19
DIAGNOSTIC ANTIBODY DEVELOPMENT PROJECT
    * EXPRES(2)ION AND ITS JOINT VENTURE PARTNER ADAPTVAC ARE
ENGAGED
IN DEVELOPMENT OF A UNIQUE CAPSID VIRUS-LIKE PARTICLE (VLP)
COVID-19 VACCINE

Source text for Eikon:  ID:nWkr8NP5ds 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on ExpreS2ion Biotech Holding AB

    See all news